{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:59:52Z","timestamp":1780747192685,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,6]]},"DOI":"10.7759\/cureus.110346","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:16:01Z","timestamp":1780744561000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Reclassification From Parkinson\u2019s Disease to Multiple System Atrophy Based on Longitudinal Clinical and Imaging Findings: A Case Report"],"prefix":"10.7759","author":[{"given":"Shoji","family":"Kikui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kashiwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Danno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry","volume":"25","author":"K\u00f6llensperger M","year":"2010","unstructured":"K\u00f6llensperger M, Geser F, Ndayisaba JP, et al.. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010, 25:2604-12. 10.1002\/mds.23192","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning GK","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, et al.. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022, 37:1131-48. 10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.67.2.189","article-title":"(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease","volume":"67","author":"Orimo S","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999, 67:189-94. 10.1136\/jnnp.67.2.189","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.5.1020","article-title":"Cardiac uptake of (123I)MIBG separates Parkinson's disease from multiple system atrophy","volume":"53","author":"Braune S","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, L\u00fccking CH. Cardiac uptake of (123I)MIBG separates Parkinson's disease from multiple system atrophy. Neurology. 1999, 53:1020-5. 10.1212\/wnl.53.5.1020","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.037028","article-title":"Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease","volume":"76","author":"Nagayama H","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2005, 76:249-51. 10.1136\/jnnp.2004.037028","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo S","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012, 18:494-500. 10.1016\/j.parkreldis.2012.01.009","journal-title":"Parkinsonism Relat Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061066","article-title":"Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease","volume":"8","author":"Umemura A","year":"2013","unstructured":"Umemura A, Oeda T, Hayashi R, Tomita S, Kohsaka M, Yamamoto K, Sawada H. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease. PLoS One. 2013, 8:e61066. 10.1371\/journal.pone.0061066","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.806122","article-title":"Differentiation of Parkinson's disease and parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging","volume":"16","author":"Ren Q","year":"2022","unstructured":"Ren Q, Wang Y, Xia X, Zhang J, Zhao C, Meng X. Differentiation of Parkinson's disease and parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging. Front Hum Neurosci. 2022, 16:806122. 10.3389\/fnhum.2022.806122","journal-title":"Front Hum Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn MM","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967, 17:427-42. 10.1212\/wnl.17.5.427","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-015-0170-z","article-title":"Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature","volume":"22","author":"Jacobson AF","year":"2015","unstructured":"Jacobson AF, Travin MI. Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature. J Nucl Cardiol. 2015, 22:980-93. 10.1007\/s12350-015-0170-z","journal-title":"J Nucl Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omae212","article-title":"Impact of selegiline on (123)I-meta-iodobenzylguanidine myocardial scintigraphy","volume":"2025","author":"Nishida K","year":"2025","unstructured":"Nishida K. Impact of selegiline on (123)I-meta-iodobenzylguanidine myocardial scintigraphy. Oxf Med Case Reports. 2025, 2025:omae212. 10.1093\/omcr\/omae212","journal-title":"Oxf Med Case Reports"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496565-diagnostic-reclassification-from-parkinsons-disease-to-multiple-system-atrophy-based-on-longitudinal-clinical-and-imaging-findings-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:16:02Z","timestamp":1780744562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496565-diagnostic-reclassification-from-parkinsons-disease-to-multiple-system-atrophy-based-on-longitudinal-clinical-and-imaging-findings-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.110346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,6]]}}}